发明名称 USES OF MONOCLONAL ANTIBODY 8H9
摘要 This invention provides a composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a suitable carrier. This invention provides a pharmaceutical composition comprising an effective amount of monoclonal antibody 8H9 or a derivative thereof and a pharmaceutically acceptable carrier. This invention also provides an antibody other than the monoclonal antibody 8H9 comprising the complementary determining regions of monoclonal antibody 8H9 or a derivative thereof, capable of binding to the same antigen as the monoclonal antibody 8H9. This invention provides a substance capable of competitively inhibiting the binding of monoclonal antibody 8H9. This invention also provides an isolated scFv of monoclonal antibody 8H9 or a derivative thereof. This invention also provides the 8H9 antigen. This invention also provides a method of inhibiting the growth of tumor cells comprising contacting said tumor cells with an appropriate amount of monoclonal antibody 8H9 or a derivative thereof.
申请公布号 EP1572077(A2) 申请公布日期 2005.09.14
申请号 EP20030716369 申请日期 2003.03.06
申请人 SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 发明人 CHEUNG, NAI-KONG, V.
分类号 A61K6/00;A61K39/395;A61K47/48;A61K49/00;A61P43/00;C07K16/00;C07K16/18;C07K16/30;C07K16/42;C12N15/11;C12N15/63;C12N15/85;C12Q1/68;C12Q1/70;G01N33/00;G01N33/53;(IPC1-7):C07K16/00 主分类号 A61K6/00
代理机构 代理人
主权项
地址